Transitioning synthetic biology innovations from the lab to commercial scale requires strategic investment, robust infrastructure, and cross-sector collaboration. This session explores the financial and operational challenges of scaling the bioeconomy in the UK and Europe, highlighting key funding mechanisms, investor perspectives, and case studies of successful scale-ups. Join this session to understand the investment landscape, technology readiness, and market adoption and hear insights for startups and stakeholders looking to bridge the gap between research and commercialization.